HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR

Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic hyperimmune globulin composition including human plasma-derived immunoglobulin G (IgG) having antibody titre between 250 and 2,500 per mg/mL o...

Full description

Saved in:
Bibliographic Details
Main Authors ROSA-BRAY, Marilyn, AUGER, Charles, ORLOVA, Natalia, ROMES, Erin, VANDEBERG, Peter, GAJARDO RODRÍGUEZ, Rodrigo, LINDSAY, Myles, WELLHOUSE, Andrea, JOSE, Marta
Format Patent
LanguageEnglish
Published 13.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic hyperimmune globulin composition including human plasma-derived immunoglobulin G (IgG) having antibody titre between 250 and 2,500 per mg/mL of IgG and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titer) between 1.5 and 15 per mg/mL of IgG for use in the treatment of coronavirus disease 2019 (COVID-19) in a patient in need thereof. A liquid therapeutic or prophylactic hyperimmune immunoglobulin composition including human plasma-derived immunoglobulin M (IgM) having a SARS-CoV-2 titre between 2,000 and 17,000 and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titre) between 200 and 70,000, methods for preparing thereof, and the use thereof for the treatment or prophylaxis of COVID-19. A method for obtaining hyperimmune human plasma from a donor for use in the treatment of COVID-19.
AbstractList Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic hyperimmune globulin composition including human plasma-derived immunoglobulin G (IgG) having antibody titre between 250 and 2,500 per mg/mL of IgG and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titer) between 1.5 and 15 per mg/mL of IgG for use in the treatment of coronavirus disease 2019 (COVID-19) in a patient in need thereof. A liquid therapeutic or prophylactic hyperimmune immunoglobulin composition including human plasma-derived immunoglobulin M (IgM) having a SARS-CoV-2 titre between 2,000 and 17,000 and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titre) between 200 and 70,000, methods for preparing thereof, and the use thereof for the treatment or prophylaxis of COVID-19. A method for obtaining hyperimmune human plasma from a donor for use in the treatment of COVID-19.
Author GAJARDO RODRÍGUEZ, Rodrigo
VANDEBERG, Peter
LINDSAY, Myles
ROMES, Erin
ORLOVA, Natalia
ROSA-BRAY, Marilyn
WELLHOUSE, Andrea
JOSE, Marta
AUGER, Charles
Author_xml – fullname: ROSA-BRAY, Marilyn
– fullname: AUGER, Charles
– fullname: ORLOVA, Natalia
– fullname: ROMES, Erin
– fullname: VANDEBERG, Peter
– fullname: GAJARDO RODRÍGUEZ, Rodrigo
– fullname: LINDSAY, Myles
– fullname: WELLHOUSE, Andrea
– fullname: JOSE, Marta
BookMark eNqNjb0KwjAUhTvo4N87XHAW7Q_oem2TJmByQ5IOTqVInKQt1HfwtW3BQZyczuF8H5xlNGu7Niyil7gaZqVSlWYgyxJQF3uyY1WQkzLkpJek3bSDYl5QAXzkxjKDVuoSvGCWEf8V6OxR6kn4fhCVQg3mgk4hcEsKEArSZNfR_N48hrD55CracuZzsQt9V4ehb26hDc-6cskhSZP4dMwyjNP_rDeTWECa
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2023218744A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2023218744A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:49:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2023218744A13
Notes Application Number: US202118000380
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230713&DB=EPODOC&CC=US&NR=2023218744A1
ParticipantIDs epo_espacenet_US2023218744A1
PublicationCentury 2000
PublicationDate 20230713
PublicationDateYYYYMMDD 2023-07-13
PublicationDate_xml – month: 07
  year: 2023
  text: 20230713
  day: 13
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies GRIFOLS WORLDWIDE OPERATIONS LIMITED
RelatedCompanies_xml – name: GRIFOLS WORLDWIDE OPERATIONS LIMITED
Score 3.4814453
Snippet Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230713&DB=EPODOC&locale=&CC=US&NR=2023218744A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU3E6JaD0rWzZulofhmRNu05MUvoh82msXQuCdMNV_BP8t72UTYcPe8sXCXfhl8td7i4I3SUgk4iVW3p_ZuU6INHUH-bmXM_g7CN5d0ZmuTLoc2F6sfE06U9q6H0TC1PlCf2qkiMColLAe1md18s_IxarfCtX7eQNmhaPbjRg2lo7Vl7NpKex4cDxJZO2ZtuDONREUPV11f9zBgVdaQ8u0vcKD87LUMWlLLeFinuM9n2YryhPUC0rGujQ3vy91kAHfP3kDcU1-lan6Nt79UHv4jwWDh6PRpgK1pYBFDm2JfdlOK6CglU75k7kSYZBycPAZZ8qrwcceU7gSPf_ADmM6FioAdsreDGnAvvPNOQUu4HkmGImhQzO0K3rRLanA0XTXwZO43Cb_N45qheLIrtAuJOQlHRSs2vAvSmxTCs1jHmuMuBbfdg2s4lau2a63N19hY5UVVlCSa-F6uXHZ3YNIrxMbirO_wDid5OF
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjakDpW9m6dbU-DMmadq0uSemHzKexdi0I0g1X8U_w3_ZSNh0-7C3kQkISfne5y30gdJeATNLM3FR7UzNXAYmG-jAzZmoGvE_LO1NtmkuDPuOGG-tP4964ht7XsTBVntCvKjkiICoFvJcVv178GbFo5Vu5bCVv0DV_dKI-VVbasfRq1roKHfRtX1BhKZbVj0OFBxWtI-vP6QR0pR14ZN9LPNgvAxmXstgUKs4h2vVhvqI8QrWsaKB9a117rYH22OrLG5or9C2P0bf76oPexVjMbewNh5hw2hIBNBm2BPNF6FVBwbIfMztyBcWg5GE4ZZ9IrwccuXZgC-f_ADGIiMflgM0V3JgRjv0RCRnBTiAYJpgKLoITdOvYkeWqsKPJ7wFO4nBz-91TVC_mRXaGcDvRUq2dGh0d3k2JaZiprs9ymQHf7MG1GeeouW2mi-3kG7TvRmw0GXn8-RIdSJK0imrdJqqXH5_ZFYjzMrmubuEH-9yWeA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HYPERIMMUNE+IGG+AND%2FOR+IGM+COMPOSITIONS+AND+METHOD+FOR+PREPARING+THEREOF+AND+METHOD+FOR+OBTAINING+HYPERIMMUNE+HUMAN+PLASMA+FROM+A+DONOR&rft.inventor=ROSA-BRAY%2C+Marilyn&rft.inventor=AUGER%2C+Charles&rft.inventor=ORLOVA%2C+Natalia&rft.inventor=ROMES%2C+Erin&rft.inventor=VANDEBERG%2C+Peter&rft.inventor=GAJARDO+RODR%C3%8DGUEZ%2C+Rodrigo&rft.inventor=LINDSAY%2C+Myles&rft.inventor=WELLHOUSE%2C+Andrea&rft.inventor=JOSE%2C+Marta&rft.date=2023-07-13&rft.externalDBID=A1&rft.externalDocID=US2023218744A1